$599
Bolus Insulin, GLP-1RA, Glucose Monitoring, Insulin Delivery, Other, Topics

ATTD 2026 Key Press Releases (March 11)

On the first day of ATTD 2026, four cardiometabolic-related news items have been observed from Skye Bioscience, Lilly, MiniMed, and LifeScan. Below, FENIX provides highlights and insights into the respective news items.

This content is for Read Less members only.
Register
Already a member? Log in here
OR
Return to Home